Cargando…

1796. Evaluation of Asymptomatic Bacteriuria in Critical Access Hospitals

BACKGROUND: The University of Washington Tele-Antimicrobial Stewardship Program (UW-TASP) provides antimicrobial stewardship education and training to rural and critical access hospitals (CAHs) in the United States through collaborative tele-mentoring. In 2021, UW-TASP implemented a pilot stewardshi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hartlage, Whitney, Chan, Jeannie D, Martinez-Paz, Natalia, Lynch, John B, Jain, Rupali, Pottinger, Paul, Bryson-Cahn, Chloe, Castillo, Alyssa Y, Kassamali-Escobar, Zahra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752570/
http://dx.doi.org/10.1093/ofid/ofac492.1426
_version_ 1784850757638422528
author Hartlage, Whitney
Chan, Jeannie D
Martinez-Paz, Natalia
Lynch, John B
Jain, Rupali
Pottinger, Paul
Bryson-Cahn, Chloe
Castillo, Alyssa Y
Castillo, Alyssa Y
Kassamali-Escobar, Zahra
author_facet Hartlage, Whitney
Chan, Jeannie D
Martinez-Paz, Natalia
Lynch, John B
Jain, Rupali
Pottinger, Paul
Bryson-Cahn, Chloe
Castillo, Alyssa Y
Castillo, Alyssa Y
Kassamali-Escobar, Zahra
author_sort Hartlage, Whitney
collection PubMed
description BACKGROUND: The University of Washington Tele-Antimicrobial Stewardship Program (UW-TASP) provides antimicrobial stewardship education and training to rural and critical access hospitals (CAHs) in the United States through collaborative tele-mentoring. In 2021, UW-TASP implemented a pilot stewardship cohort to reduce antibiotic treatment of asymptomatic bacteriuria (ASB). We sought to quantify the overall prevalence of ASB and proportion treated in participating hospitals. METHODS: Patients undergoing urine testing were identified through local electronic medical records and microbiology data. CAHs adjudicated their own cases and reported demographics, symptoms of urinary tract infection, systemic inflammatory response symptoms (SIRS), location at the time of culture, laboratory results, and antibiotic treatment through a RedCap collection tool. The data form was created and analyzed by UW-TASP faculty. This study was waived by the University of Washington institutional review board. RESULTS: Nineteen CAHs in 5 states participated in this pilot. Eight submitted urine analysis and culture data for 417 patients. Seventy-seven percent of patients were female and the median age was 70. The emergency department was the most common culture collection location (274/417, 66%), followed by ambulatory care clinics (111/417, 27%), and nursing facilities (13/417, 3%). SIRS criteria and/or organ dysfunction were present in 149/417 patients (36%). Two hundred sixty patients (62%) had a positive culture with Escherichia coli being the most common implicated organism (167/260, 64%). ASB was identified in 69/260 patients (27%), and antibiotics were prescribed for 53/69 (77%) of those with ASB. Oral antibiotics were prescribed for 311 (75%) patients. Of those, 22% were prescribed a fluoroquinolone. Median treatment duration was 7 days (range, 1-14). CONCLUSION: Although the prevalence of ASB was only 27% among 417 patients, treatment of ASB was high at 77%. High numbers of culture collections from the emergency department and ambulatory care settings identify these locations as future foci for stewardship interventions in CAHs. Low hanging fruit for intervention include reducing unnecessary fluoroquinolone use and reducing duration of antibiotic therapy. DISCLOSURES: Chloe Bryson-Cahn, MD, Alaska Airlines: Advisor/Consultant.
format Online
Article
Text
id pubmed-9752570
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-97525702022-12-16 1796. Evaluation of Asymptomatic Bacteriuria in Critical Access Hospitals Hartlage, Whitney Chan, Jeannie D Martinez-Paz, Natalia Lynch, John B Jain, Rupali Pottinger, Paul Bryson-Cahn, Chloe Castillo, Alyssa Y Castillo, Alyssa Y Kassamali-Escobar, Zahra Open Forum Infect Dis Abstracts BACKGROUND: The University of Washington Tele-Antimicrobial Stewardship Program (UW-TASP) provides antimicrobial stewardship education and training to rural and critical access hospitals (CAHs) in the United States through collaborative tele-mentoring. In 2021, UW-TASP implemented a pilot stewardship cohort to reduce antibiotic treatment of asymptomatic bacteriuria (ASB). We sought to quantify the overall prevalence of ASB and proportion treated in participating hospitals. METHODS: Patients undergoing urine testing were identified through local electronic medical records and microbiology data. CAHs adjudicated their own cases and reported demographics, symptoms of urinary tract infection, systemic inflammatory response symptoms (SIRS), location at the time of culture, laboratory results, and antibiotic treatment through a RedCap collection tool. The data form was created and analyzed by UW-TASP faculty. This study was waived by the University of Washington institutional review board. RESULTS: Nineteen CAHs in 5 states participated in this pilot. Eight submitted urine analysis and culture data for 417 patients. Seventy-seven percent of patients were female and the median age was 70. The emergency department was the most common culture collection location (274/417, 66%), followed by ambulatory care clinics (111/417, 27%), and nursing facilities (13/417, 3%). SIRS criteria and/or organ dysfunction were present in 149/417 patients (36%). Two hundred sixty patients (62%) had a positive culture with Escherichia coli being the most common implicated organism (167/260, 64%). ASB was identified in 69/260 patients (27%), and antibiotics were prescribed for 53/69 (77%) of those with ASB. Oral antibiotics were prescribed for 311 (75%) patients. Of those, 22% were prescribed a fluoroquinolone. Median treatment duration was 7 days (range, 1-14). CONCLUSION: Although the prevalence of ASB was only 27% among 417 patients, treatment of ASB was high at 77%. High numbers of culture collections from the emergency department and ambulatory care settings identify these locations as future foci for stewardship interventions in CAHs. Low hanging fruit for intervention include reducing unnecessary fluoroquinolone use and reducing duration of antibiotic therapy. DISCLOSURES: Chloe Bryson-Cahn, MD, Alaska Airlines: Advisor/Consultant. Oxford University Press 2022-12-15 /pmc/articles/PMC9752570/ http://dx.doi.org/10.1093/ofid/ofac492.1426 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstracts
Hartlage, Whitney
Chan, Jeannie D
Martinez-Paz, Natalia
Lynch, John B
Jain, Rupali
Pottinger, Paul
Bryson-Cahn, Chloe
Castillo, Alyssa Y
Castillo, Alyssa Y
Kassamali-Escobar, Zahra
1796. Evaluation of Asymptomatic Bacteriuria in Critical Access Hospitals
title 1796. Evaluation of Asymptomatic Bacteriuria in Critical Access Hospitals
title_full 1796. Evaluation of Asymptomatic Bacteriuria in Critical Access Hospitals
title_fullStr 1796. Evaluation of Asymptomatic Bacteriuria in Critical Access Hospitals
title_full_unstemmed 1796. Evaluation of Asymptomatic Bacteriuria in Critical Access Hospitals
title_short 1796. Evaluation of Asymptomatic Bacteriuria in Critical Access Hospitals
title_sort 1796. evaluation of asymptomatic bacteriuria in critical access hospitals
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752570/
http://dx.doi.org/10.1093/ofid/ofac492.1426
work_keys_str_mv AT hartlagewhitney 1796evaluationofasymptomaticbacteriuriaincriticalaccesshospitals
AT chanjeannied 1796evaluationofasymptomaticbacteriuriaincriticalaccesshospitals
AT martinezpaznatalia 1796evaluationofasymptomaticbacteriuriaincriticalaccesshospitals
AT lynchjohnb 1796evaluationofasymptomaticbacteriuriaincriticalaccesshospitals
AT jainrupali 1796evaluationofasymptomaticbacteriuriaincriticalaccesshospitals
AT pottingerpaul 1796evaluationofasymptomaticbacteriuriaincriticalaccesshospitals
AT brysoncahnchloe 1796evaluationofasymptomaticbacteriuriaincriticalaccesshospitals
AT castilloalyssay 1796evaluationofasymptomaticbacteriuriaincriticalaccesshospitals
AT castilloalyssay 1796evaluationofasymptomaticbacteriuriaincriticalaccesshospitals
AT kassamaliescobarzahra 1796evaluationofasymptomaticbacteriuriaincriticalaccesshospitals